Srivar Pharma Private Limited, a active private limited company, was established on 09 September 2009 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2009PTC064986. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹20.00 Cr.
Formerly known as Dsr Labs Private Limited, Eva Drugs Private Limited. It upholds a compliant status. Employing 20 professional, Its leadership includes Prabhavathi Sistla (Whole-Time Director), Ramakrishnan Sishtla (Managing Director). Past directors included Buddineni Jaya Rama Rao, Dhani Reddy Sudarsana Reddy, Upendram Raju. It holds ₹8.58 Cr open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sy.No-104, Rtc Colony, Lal Bazar, Secunderabad, Hyderabad, Telangana, 500011.
U24100TG2009PTC064986
064986
09 September 2009
₹20.00 Cr
₹20.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Srivar Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabhavathi Sistla | Whole-Time Director | 05 Oct 2017 | Current |
| Ramakrishnan Sishtla | Managing Director | 05 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Nov 2011 | Past |
| Pramod Abcsdd | Director | 04 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 15 Jun 2015 | Past |
| Pramod Abcsdd | Additional Director | 19 Apr 2024 | Past |
| Pramod Abcsdd | Whole-Time Director | 28 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Srivar Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.29% decrease. The company also saw a substantial fall in profitability, with a 71.69% decrease in profit. The company's net worth Soared by an impressive increase of 85.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Srivar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹85,800,000.00
₹50,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2022 | Others | ₹5.80 M | Open |
| 15 Mar 2022 | Others | ₹8.00 Cr | Open |
| 20 Jul 2015 | Andhra Pradesh State Financial Corporation | ₹1.61 Cr | Satisfied |
| 27 Jun 2013 | Andhra Pradesh State Financial Corporation | ₹3.39 Cr | Satisfied |
Explore comprehensive loan charge details -
Srivar Pharma has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Srivar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srivar Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Srivar Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Srivar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge with Others amounted to Rs. 0.58 Cr with Charge ID 100588363 was registered on 09 Jun 2022. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100563728 was registered on 15 Mar 2022. was completed.
The activity A charge registered on 20 Jul 2015 via Charge ID 10581039 with Andhra Pradesh State Financial Corporation was fully satisfied on 03 Feb 2022. was completed.
The activity A charge registered on 27 Jun 2013 via Charge ID 10437957 with Andhra Pradesh State Financial Corporation was fully satisfied on 03 Feb 2022. was completed.
The CIN of Srivar Pharma Private Limited is U24100TG2009PTC064986.
Srivar Pharma Private Limited is headquartered at Sy.No-104, Rtc Colony, Lal Bazar, Secunderabad, Hyderabad, Telangana, 500011.
Srivar Pharma Private Limited was incorporated on 09 September 2009.
The current directors of Srivar Pharma Private Limited are
The primary industry of Srivar Pharma Private Limited is Manufacturing.
Srivar Pharma Private Limited is unlisted.
The authorized capital of Srivar Pharma Private Limited is ₹20.00 Cr, and the paid-up capital is ₹20.00 Cr.
The compliance status of Srivar Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX